Source: Medical Device Network

Axonics: Axonics' sacral neuromodulation device cleared in Australia

Axonics says that its device significantly reduces the user's need to recharge as it marks its second clearance in only a year in the market. The post Axonics' sacral neuromodulation device cleared in Australia appeared first on Medical Device Network.

Read full article »
Annual Revenue
$100-500M
Employees
500-1.0K
Raymond W. Cohen's photo - Co-Founder & CEO of Axonics

Co-Founder & CEO

Raymond W. Cohen

CEO Approval Rating

91/100

Read more